Patients | Data points | 3.9 mmol/L (70 mg/dL) | 3.5 mmol/L (63 mg/dL) | 3.0 mmol/L (54 mg/dL) | ||||||||
% time hypo | Hypos/ day | Mean duration (min) | % time hypo | P value | Hypos/ day | Mean duration (min) | % time hypo | Hypos/ day | Mean duration (min) | |||
All | 63 | 3 397 713 | 6.90 | 2.4 | 42.4 | 3.26 | 1.3 | 36.4 | 1.21 | 0.5 | 34.6 | |
Mutation positive | 43 | 1 919 470 | 6.39 | 2.1 | 44.1 | 3.01 | <0.001 | 1.2 | 36.8 | 1.11 | 0.5 | 33.3 |
Mutation negative | 20 | 1 478 243 | 7.56 | 2.7 | 40.6 | 3.58 | 1.4 | 36.0 | 1.35 | 0.5 | 36.1 | |
On CHI medications | 49 | 2 818 276 | 5.53 | 1.9 | 42.6 | 2.54 | <0.001 | 1.0 | 36.0 | 0.91 | 0.4 | 32.7 |
Off CHI medications | 14 | 579 437 | 13.6 | 4.7 | 41.8 | 6.74 | 2.6 | 37.2 | 2.65 | 1.0 | 38.3 | |
All (non-ADA) | 63 | 3 397 713 | 7.36 | 4.1 | 25.9 | 3.61 | 2.4 | 21.5 | 1.40 | 19.1 | 19.1 |
P value=p value for difference in % time hypo (<3.5mmol/L) between subgroups, calculated via Χ2 test. Mean length is presented in minutes.
Mutation positive=any known CHI-causing mutation demonstrated.
Mutation negative=either CHI gene panel negative or not done.
Hypos=hypoglycemic episodes.
All values are provided as per ADA criteria unless otherwise specified.
ADA, American Diabetes Association; CHI, congenital hyperinsulinism.